Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.58 USD | -0.52% | -1.15% | -20.28% |
May. 07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.